Erik W Bloomquist
6PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 05, 2024
FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Cisplatin-Ineligible Locally Advanced or Metastatic Urothelial Carcinoma.William F Maguire, Daniel Lee, Chana Weinstock
|Dec 21, 2023
FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With <i>BRCA</i>-Mutated Metastatic Castration-Resistant Prostate Cancer.Jaleh Fallah, Jianjin Xu, Chana Weinstock
|Aug 18, 2023
FDA Approval Summary: Ribociclib Indicated for Male Patients with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer.Jennifer J Gao, Christy L Osgood, Zhou Feng
|Apr 27, 2023
US Food and Drug Administration Expanded Adjuvant Indication of Abemaciclib in High-Risk Early Breast Cancer.Melanie Royce, Flora Mulkey, Christy Osgood
|Feb 13, 2023
US Food and Drug Administration Approval Summary: Fam-Trastuzumab Deruxtecan-nxki for Human Epidermal Growth Factor Receptor 2-Low Unresectable or Metastatic Breast Cancer.Preeti Narayan, Asma Dilawari, Christy Osgood
Pageof 1
Frequent Collaborators
6 joint publications
Laleh Amiri-Kordestani
5 joint publications
Shenghui Tang
5 joint publications
Richard Pazdur
4 joint publications
William F Pierce
2 joint publications
Zhou Feng
2 joint publications
Paul G Kluetz
2 joint publications
Xin Gao
2 joint publications
Elaine Chang
1 joint publications
Daniel L Suzman
1 joint publications
Asma Dilawari
